Cargando…

Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma

Pathways that govern cellular bioenergetics are deregulated in tumor cells and represent a hallmark of cancer. Tumor cells have the capacity to reprogram pathways that control nutrient acquisition, anabolism and catabolism to enhance their growth and survival. Tumorigenesis requires the autonomous r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rana, Priyanka S., Goparaju, Krishna, Driscoll, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285382/ https://www.ncbi.nlm.nih.gov/pubmed/37361580 http://dx.doi.org/10.3389/fonc.2023.1141851

Ejemplares similares

A New Shut-Off
por: Dowd, J. Henry
Publicado: (1899)

Metabolic Vulnerabilities in Multiple Myeloma
por: Lim, Julia S. L., et al.
Publicado: (2022)

Cancer Energy Metabolism: Shutting Power off Cancer Factory
por: Kim, Soo-Youl
Publicado: (2018)

MCP-1 targeting: Shutting off an engine for tumor development
por: Wang, Liang, et al.
Publicado: (2022)

Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
por: Rana, Priyanka S., et al.
Publicado: (2022)

Lipid metabolic vulnerabilities of multiple myeloma
por: Torcasio, Roberta, et al.
Publicado: (2023)

Evolution of the shut-off steps of vertebrate phototransduction
por: Lamb, Trevor D., et al.
Publicado: (2018)

Road testing new CAR design strategies in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2022)

Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes
por: Fairfield, Heather, et al.
Publicado: (2021)

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies
por: Fultang, Livingstone, et al.
Publicado: (2021)

Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
por: Jovanović, Katarina K., et al.
Publicado: (2019)

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Shutting down the power supply for DNA repair in cancer cells
por: van Vugt, Marcel A.T.M.
Publicado: (2017)

Competence shut-off by intracellular pheromone degradation in salivarius streptococci
por: Knoops, Adrien, et al.
Publicado: (2022)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
por: Nair, Remya, et al.
Publicado: (2022)

Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
por: Matamala Montoya, María, et al.
Publicado: (2023)

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2019)

Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma
por: Nguyen, Phuong, et al.
Publicado: (2019)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
por: Wu, Shaojie, et al.
Publicado: (2021)

Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance
por: Fasanya, Adebayo A, et al.
Publicado: (2016)

Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses
por: Fros, Jelke J., et al.
Publicado: (2016)

Quantitative Kinetic Analyses of Shutting Off a Two-Component System
por: Gao, Rong, et al.
Publicado: (2017)

A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment
por: Liu, Xu, et al.
Publicado: (2022)

Therapeutic Advancements in Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2014)

Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment
por: van der Schans, Jort J., et al.
Publicado: (2020)

Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma
por: Russignan, Anna, et al.
Publicado: (2021)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022)

Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors
por: Schwestermann, Jonas, et al.
Publicado: (2022)

Trading Off Global Fuel Supply, CO(2) Emissions and Sustainable Development
por: Wagner, Liam, et al.
Publicado: (2016)

Editorial: Molecular Mechanisms of Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine
por: Ke, Mengying, et al.
Publicado: (2021)

Stochastic coreceptor shut-off is restricted to the CD4 lineage maturation pathway
Publicado: (1995)

Shut the Door
Publicado: (1874)

Association between metabolic obesity phenotypes and multiple myeloma hospitalization burden: A national retrospective study
por: Zhang, Yue, et al.
Publicado: (2023)

Current Role of Radiation Therapy for Multiple Myeloma
por: Talamo, Giampaolo, et al.
Publicado: (2015)

An Uncommon Cause of Acute Encephalopathy in Multiple Myeloma
por: Al Zeyoudi, Jawaher, et al.
Publicado: (2021)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Editorial: T-cell directed therapies in multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2023)

The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment
por: Khalife, Jihane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffjldl9bbgig31l554tl4f25s7